Phreesia to Support Parkinson’s Disease Awareness and Research with The Michael J. Fox Foundation

Phreesia is supporting The Michael J. Fox Foundation to raise educational awareness and research onramps for the Parkinson’s disease community.
News-Medical.Net

Managing misfolded proteins to prevent Parkinson’s disease

The protein alpha-synuclein is abundant in healthy brains and plays an important role in enabling communication between nerve ...

Ask Mayo Clinic: Learn the key difference between essential tremor and Parkinson's disease

Some people live with essential tremor for years and organically find ways to adapt. Others may begin avoiding activities.
Healio

Tavapadon brings novel option to treat Parkinson's disease by focusing on D1/D5 receptors

Tavapadon, a treatment for Parkinson’s disease recently approved by the FDA, provides a novel option for healthcare providers ...

Alector soars as Roche licenses Parkinson's therapy for up to $1.27 billion

Oct 5 (Reuters) - Swiss drugmaker Roche will pay up to $1.27 billion to license Alector's experimental treatment for ...

Altru Family YMCA annual 'Pumpkins for Parkinson's Day' set for Wednesday, Oct. 7

The Altru Family YMCA is hosting the 11th annual "Pumpkins for Parkinson's" fundraising event Wednesday, Oct. 7, at its ...

CBS News New York sports producer Joe McLaughlin shares his journey with Parkinson's disease

More than 1 million people in the U.S. are currently living with Parkinson's disease. CBS News New York sports producer Joe ...

Alector Signs $1.27 Billion Genentech License Agreement for Parkinson’s Disease Program

Alector will receive $100 million upfront and could earn up to $1. 17 billion in additional milestones while Genentech assumes responsibility for developing and commercializing AL050 globally.